Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Nordøy A Lipids and thrombogenesis. 1981 Ann. Clin. Res. pmid:7018362
Moncada S and Vane JR Prostacyclin and blood coagulation. 1981 Drugs pmid:7018874
Ylikorkala O et al. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass. 1981 J. Thorac. Cardiovasc. Surg. pmid:7019583
Hales CA et al. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. 1981 J. Clin. Invest. pmid:7021593
Hyman AL et al. Prostaglandins and the lung. 1981 Med. Clin. North Am. pmid:7024664
Baroody RA and Bito LZ The impermeability of the basic cell membrane to thromboxane-B2' prostacyclin and 6-keto-PGF 1 alpha. 1981 Prostaglandins pmid:7010455
Rosenfeld J et al. Extractive alkylation of prostaglandins. 1981 Prostaglandins pmid:7010456
Tanaka M et al. Increased prostacyclin synthesizing activity in human ripening uterine cervix. 1981 Prostaglandins pmid:7010458
Gonzalez-Crussi F et al. Prostaglandins in histiocytosis-X. PG synthesis by histiocytosis-X cells. 1981 Am. J. Clin. Pathol. pmid:6970520
Araki H et al. Mechanism of protection against arachidonate induced sudden death by glucocorticoid. 1981 Prostaglandins pmid:7232764
Tyler HM et al. Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase. 1981 Lancet pmid:6110861
Vermylen J et al. Thromboxane synthetase inhibition as antithrombotic strategy. 1981 Lancet pmid:6112447
Feuerstein N et al. 3-deazaadenosine, a transmethylase inhibitor, suppresses the effect of lipopolysaccharide on release of prostacyclin and thromboxane. 1981 J. Pharm. Pharmacol. pmid:6115021
Satoh K et al. Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders. 1981 Jpn. Circ. J. pmid:7321143
Matsumoto M et al. Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease. 1981 Prostaglandins Med pmid:7323212
Smith MC and Dunn MJ Impaired platelet thromboxane production in renal failure. 1981 Nephron pmid:7329487
Lagarde M et al. Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid. 1981 Biochem. Biophys. Res. Commun. pmid:7259783
Livio M et al. Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats. 1981 Atherosclerosis pmid:7259827
Sterin-Borda L et al. Stimulating effect of thromboxane B2 on isolated rat atria. 1981 Experientia pmid:7262286
Hirsh PD et al. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. 1981 N. Engl. J. Med. pmid:6894016
Allan G and Levi R Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro. 1981 J. Pharmacol. Exp. Ther. pmid:6894166
Sobel M et al. Circulating platelet products in unstable angina pectoris. 1981 Circulation pmid:6450001
Catalano PM et al. Platelet recovery from aspirin inhibition in vivo; differing patterns under various assay conditions. 1981 Blood pmid:7448419
Taylor L et al. Prostaglandin production and cellular aging. 1981 Mech. Ageing Dev. pmid:6946268
Young MK et al. Aging: effects on the prostaglandin production by skeletal muscle of male rhesus monkeys (Macaca mulatta). 1981 Mech. Ageing Dev. pmid:6946269
Wonders TR et al. Reduced plasma thromboxane elevation during partial cardiopulmonary bypass in thrombocytopenic sheep. 1981 Trans Am Soc Artif Intern Organs pmid:7331082
Mezzano D et al. Evidence that platelet buoyant density, but not size, correlates with platelet age in man. 1981 Am. J. Hematol. pmid:7270546
Hirsh PD et al. Prostaglandins and ischemic heart disease. 1981 Am. J. Med. pmid:7032286
Dunham BM et al. Role of prostaglandins in positive end-expiratory pressure-induced negative inotropism. 1981 Am. J. Physiol. pmid:7034549
Strano A et al. Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction. 1981 Thromb. Haemost. pmid:7036402
Boyd JA and Eling TE Prostaglandin release and the interaction of platelets with the pulmonary vasculature of rat and guinea pig. 1980 Jul 1-15 Thromb. Res. pmid:7003800
Patrono C et al. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. 1980 Feb 1-15 Thromb. Res. pmid:7368167
Koh H et al. A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. 1980 Feb 1-15 Thromb. Res. pmid:7368170
Kosaki G et al. The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. 1980 Dec 1-15 Thromb. Res. pmid:6785893
Spagnuolo PJ et al. Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. 1980 J. Clin. Invest. pmid:6772674
Best LC et al. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. 1980 Thromb. Haemost. pmid:6773171
Stuart MJ et al. The influence of albumin and calcium on human platelet arachidonic acid metabolism. 1980 Blood pmid:6766753
Challis JR and Patrick JE The production of prostaglandins and thromboxanes in the feto-placental unit and their effects on the developing fetus. 1980 Semin. Perinatol. pmid:6992278
Ahnfelt-Rønne I et al. Macrophages from adjuvent arthritic rats preferentially synthetize prostacyclin. 1980 Agents Actions pmid:6992544
Crutchley DJ et al. Enhanced thromboxane B2 release from challenged guinea pig lung after oxygen exposure. 1980 Am. Rev. Respir. Dis. pmid:6155814
Cella G et al. In vivo platelet release reaction in patients with heart valve prosthesis. 1980 Haemostasis pmid:6157609
Best LC et al. Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets. 1980 Biochim. Biophys. Acta pmid:6251913
Heggers JP et al. Evaluation of burn blister fluid. 1980 Plast. Reconstr. Surg. pmid:6770396
Galli C et al. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets. 1980 Pharmacol Res Commun pmid:7393988
Oka M and Manku MS Spironolactone decreases the formation of prostaglandins and related substances from arachidonic acid in rat vascular rings and human platelets. 1980 Prostaglandins Med pmid:7394062
Langs DA et al. Thromboxane molecules are not hairpin conformers. 1980 Adv Prostaglandin Thromboxane Res pmid:7386281
Bailey JM Essential fatty acid requirements and metabolism of cells in tissue culture. 1980 Adv Prostaglandin Thromboxane Res pmid:7386288
Maclouf J et al. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin. 1980 Eur. J. Biochem. pmid:7408901
Vanderhoek JY et al. 15-hydroxy-5,8,11,13-eicosatetraenoic acid: A potent and selective inhibitor of platelet lipoxygenase. 1980 J. Biol. Chem. pmid:6771259
Ali M et al. Inhibition of human platelet cyclooxygenase by alpha-tocopherol. 1980 Prostaglandins Med pmid:6771778